Scholars Central

Conference abstractPublished 2 Aug 2019

Pharmacological optimization of the conditioning regimen for hematopoietic stem cell transplantation

Authors: Ben C Valdez, Borje S Andersson

The University of Texas MD Anderson Cancer Center, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hematopoietic stem cell transplantation is an effective treatment for a variety of hematological disorders. Its success partly depends on the optimization of the pre-transplant conditioning regimen. To identify an efficacious regimen, we exposed cells to different drug combinations, analyzed their cytotoxicity and identified their molecular mechanisms of interaction using various techniques. We have shown the synergistic cytotoxicity of DNA Alkylating Agents (AA) and Nucleoside Analogs (NA) in leukemia and lymphoma cells and proposed a mechanistic model called the loop of death. Exposure of cells to a nucleoside analog initiates DNA damage resulting in chromatin remodeling and makes genomic DNA more susceptible to DNA alkylation. DNA damage response is then activated and the loop of DNA damage, chromatin remodeling and DNA alkylation continues until the tumor cells commit to apoptosis. Using this model and the [AA+NA] combination as a backbone to identify drugs that may further enhance its anti-tumor activity, we hypothesized that epigenetic modifiers would amplify the loop of death. Indeed, inhibitors of Histone Deacetylases (HDACi) and DNA Methyl Transferases (DNMTi), which facilitate relaxation of chromatin, were found to be synergistic with [AA+NA]. Since active DNA repair may contribute to decreased efficacy of these drug combinations, we also examined the inclusion of DNA repair inhibitors such as olaparib. Addition of olaparib to [AA+NA] caused significant apoptosis by activation of the DNA, damage response, inhibition of PARP activity and DNA repair, production of reactive oxygen species and depolarization of the mitochondrial membranes. Overall, our preclinical and clinical results suggest that the conditioning regimen for HSCT may be optimized by combining drugs that provide synergistic cytotoxicity based on their molecular mechanisms of action.

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Toxicology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalToxicology: Open Access
  • SubjectToxicology
  • BylineArticles whose byline prints “Ben C Valdez”
  • BylineArticles whose byline prints “Borje S Andersson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels